StockData
Puma Biotechnology, Inc. logo

Puma Biotechnology, Inc. (PBYI) stock

PBYINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 14/3019% below fair value
$7.22+0.08 (+1.12%)

Close on Nov 18, 2026Market cap $372.70MP/E 13.9Yield –

Puma Biotechnology operating margin

Operating margin is operating income as a percentage of revenue.

Puma Biotechnology's operating margin for the twelve months ending Jun 30, 2026 was 13.2%. For fiscal 2025 it was 16.3%, against 13.4% the year before. The highest annual figure on record is 16.3% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202516.3%+2.9
FY2024Dec 31, 202413.4%−0.4
FY2023Dec 31, 202313.9%+3.4
FY2022Dec 31, 202210.4%+9.9
FY2021Dec 31, 20210.5%+14.0
FY2020Dec 31, 2020-13.5%+0.8
FY2019Dec 31, 2019-14.3%+23.4
FY2018Dec 31, 2018-37.7%+1018.4
FY2017Dec 31, 2017-1056.1%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202613.4%+0.8
Q1 FY2026Mar 31, 2026-8.5%−17.2
Q4 FY2025Dec 31, 202522.7%+0.0
Q3 FY2025Sep 30, 202517.6%−9.8
Q2 FY2025Jun 30, 202512.7%+17.3
Q1 FY2025Mar 31, 20258.7%+13.9
Q4 FY2024Dec 31, 202422.6%+2.1
Q3 FY2024Sep 30, 202427.4%+12.1
Q2 FY2024Jun 30, 2024-4.6%−13.6
Q1 FY2024Mar 31, 2024-5.3%−13.5
Q4 FY2023Dec 31, 202320.5%+5.3
Q3 FY2023Sep 30, 202315.3%+11.1
Q2 FY2023Jun 30, 20239.0%−11.3
Q1 FY2023Mar 31, 20238.3%+9.9
Q4 FY2022Dec 31, 202215.3%+2.9
Q3 FY2022Sep 30, 20224.2%+23.6
Q2 FY2022Jun 30, 202220.3%+51.4
Q1 FY2022Mar 31, 2022-1.6%−22.2
Q4 FY2021Dec 31, 202112.3%+33.6
Q3 FY2021Sep 30, 2021-19.4%+4.5
Q2 FY2021Jun 30, 2021-31.2%−41.3
Q1 FY2021Mar 31, 202120.5%+48.3
Q4 FY2020Dec 31, 2020-21.2%−7.4
Q3 FY2020Sep 30, 2020-23.9%+1.7
Q2 FY2020Jun 30, 202010.1%+57.9
Q1 FY2020Mar 31, 2020-27.8%−37.8
Q4 FY2019Dec 31, 2019-13.8%+12.3
Q3 FY2019Sep 30, 2019-25.6%−7.6
Q2 FY2019Jun 30, 2019-47.8%+33.8
Q1 FY2019Mar 31, 20199.9%+45.1
Q4 FY2018Dec 31, 2018-26.1%+268.1
Q3 FY2018Sep 30, 2018-18.0%+1256.3
Q2 FY2018Jun 30, 2018-81.6%–
Q1 FY2018Mar 31, 2018-35.2%–
Q4 FY2017Dec 31, 2017-294.2%–
Q3 FY2017Sep 30, 2017-1274.3%–

More Puma Biotechnology figures

See a number that looks wrong?